PPA-037
PPA-037 is an orally active, highly potent and selective inhibitor of cyclin-dependent kinase 12 (CDK12) . PPA-037 induces the degradation of cyclin K (Cyclin K), enhancing antiproliferative effects on tumor cells. PPA-037 is promising for research of cancers[1].
Product Specifications
CAS Number
2883700-83-0
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
C1(CNC2=CC(N[C@H]3CCNC3)=NC4=C(C5CC5)C=NN24)=CC=C(C6=CC=CC=N6)C=C1
Molecular Formula
C25H27N7
Molecular Weight
425.53
References & Citations
[1]Edward AINSCOW, et al. Substituted pyrazolo[1,5-a]pyrimidine-7-amine compounds as cdk inhibitors and their therapeutic use. WO2022263604A1. 2022-12-22
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK12
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15224724 1 Vial
Lentiviral mouse Adarb2 shRNA (UAS) - Lentiviral mouse Adarb2 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 
040092-AP 200 µL
PKRD1 (Serine/threonine-protein kinase D1, Protein kinase C mu type, Protein kinase D, nPKC-D1, nPKC-mu, PKD, PKD1, PRKCM, EC: 2.7.11.13) discontinued
Sign In for Pricing
View Details